In the treated right-sided tumors, XPDT therapy significantly increased T cell infiltration in the tumor, as indicated by the significant increase in CD3+ T cells (inclusive of CD4+ and CD8+ T cells) in the RT + pYSM–treated tumors when compared to the control group (Fig. 7, A and B). Here, CD8A is linked to neoplasm.